Trademark: 86966146
Word
BIOLAB FARMACÊUTICA
Status
Dead
Status Code
602
Status Date
Sunday, October 1, 2017
Serial Number
86966146
Mark Type
4000
Filing Date
Wednesday, April 6, 2016
Abandoned Date
Tuesday, August 29, 2017

Trademark Owner History

Classifications
5 Medicines for human and veterinary use in the treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; adjuvants for medical purposes; pharmaceutical preparations for human and veterinary use for the treatment and prevention of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; chemical-pharmaceutical preparations for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; nutritional complements in the nature of nutritional supplements; mineral food supplements; vitamins and mineral supplements; dietetic food, namely, cereals, powdered milk for babies, salt, and sugar adapted for medical use
35 Commercialization of pharmaceutical products in the nature of products for use in human and veterinary treatment for disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; nutritional supplements; mineral food supplements; vitamins and mineral supplements; dietetic foods, namely, cereals, powdered milk for babies, salt, and sugar adapted for medical use
BIO LAB FARMACÊUTICA

Trademark Events
Oct 2, 2017
Abandonment Notice Mailed - Failure To Respond
Oct 1, 2017
Abandonment - Failure To Respond Or Late Response
Feb 28, 2017
Notification Of Final Refusal Emailed
Feb 28, 2017
Final Refusal E-Mailed
Feb 28, 2017
Final Refusal Written
Feb 2, 2017
Teas/Email Correspondence Entered
Feb 1, 2017
Correspondence Received In Law Office
Feb 1, 2017
Teas Response To Office Action Received
Aug 1, 2016
Notification Of Non-Final Action E-Mailed
Aug 1, 2016
Non-Final Action E-Mailed
Aug 1, 2016
Non-Final Action Written
Jul 21, 2016
Assigned To Examiner
Apr 12, 2016
Notice Of Pseudo Mark E-Mailed
Apr 11, 2016
New Application Office Supplied Data Entered In Tram
Apr 9, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24